08:00 Registration opens
09:00 Opening remarks
Morning session, chaired by Nicholas Darton
09:15 Drug discovery – some recent trends
Alan Smith (Cambridge in America, former CSO Genzyme, USA)
09:45 Measuring changes to the hydration water around proteins by terahertz spectroscopy
Chris van der Walle (MedImmune, UK)
10:15 Speed Networking
11:15 A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components
Prof. Randy Mrsny (University of Bath, UK)
11:45 Exhibitors highlight
12:30 Lunch Break, Exhibition and Posters
Afternoon session, chaired by Bernardo Perez-Ramirez (Genzyme, USA)
13:45 Introduction
14:00 Starting with the end in mind. New approaches to biopharmaceutical development to reduce product attrition
Andreas Arnell (Lonza, UK)
14:30 The devil you know: look early, look hard and minimize the unexpected
Mark Krebs (Biogen, USA)
15:00 Coffee break, Exhibition and Posters
15:30 Formulation Patents for Biologics: Challenges and Strategies for Innovators and Biosimilar Developers
Tim Shea (Sterne, Kessler, Goldstein & Fox, USA)
16:00 Discussion panel: Value of formulation throughout the product life – successful products, life cycle management & intellectual property
17:00 Concluding remarks
17:10 Conference ends